Twist Bioscience Corporation has promoted former chief commercial officer Patrick Finn to the newly created position of president and chief operating officer, a press release reported.
“Paddy joined Twist eight years ago, establishing our sales and marketing team and growing sales from $2 million in fiscal 2016 to sales of $184 million for the 12 months ended June 30, 2022. Over his tenure at Twist, he has excelled and taken greater spans of control, with increasing responsibility, resulting in this promotion,” CEO and co-founder of Twist Bioscience, Emily M. Leproust, said. “As we expand our footprint globally, Paddy brings a customer-centric focus to every aspect of our operations, augmenting our senior leadership team across all areas of the business, and I look forward to his forward-thinking, strategic leadership as we continue to increase our market share across synthetic biology, NGS and biopharma, as well as launch a commercial product for data storage.”
Under the newly established role, Finn will be responsible for leading Twist’s commercial team, which is currently overseen by sales leaders across the Americas, Europe and APAC, and their respective operations.
Finn began his tenure with Twist in 2015. He is credited with making significant contributions to the company’s commercial synthetic DNA products launch, earning his 2019 promotion to chief commercial officer, at which point he was tasked with expanding the products’ reach and commercial development on a global scale.
“During my time at Twist, I have had the privilege of working closely with our customers and with the Twist teams that interact with them directly. I look forward to the expanded responsibility of overseeing operations to drive exceptional product quality, superior customer experience, faster turnaround times and fiscal responsibility to bring our solutions to established and new customers globally,” Finn said.
Before joining the company, he served as vice president of Enzymatics’ North American and European sales, and as the director of business development at Agilent Technologies, and director of product development for Beckman Coulter, among several other roles.